Age and NSAID use were linked with a longer time to conception for women with SpA. Researchers urge patients wanting to get pregnant to be cautious about using them.
Researchers found that second-line immunosuppression for severe immune-related adverse events was associated with impaired survival outcomes among patients with advanced melanoma.
The drug was statistically superior to the placebo across all key endpoints in phase 2b study, regardless of patient response or intolerance to conventional and advanced therapies.
People with moderate-to-severe ulcerative colitis benefit from a combination of these monoclonal antibodies, compared with induction with either agent alone, according to a new phase 2a study.